First, we wanted to ascertain the consequences of altered myeloid Trib1 levels in metabolic tissues as this gene has been identified as a risk locus for hyperlipidaemia in a number of GWAS analyses (29–31) but its molecular mechanism impacting on lipid homeostasis is still incompletely understood. Here, TRIB1 is linked to hyperlipidemia.